rhBMP-2 provides no benefit in treatment of open tibial fractures with a reamed IM nail .
This report has been verified
by one or more authors of the
original publication.
Recombinant human bone morphogenetic protein-2: A randomized trial in open tibial fractures treated with reamed nail fixation.
J Bone Joint Surg Am. 2011 May 4;93(9):801-8. Epub 2011 Mar 31.277 patients with an open tibial shaft fracture were randomized to either receive the standard of care or to the treatment group, which received the standard of care plus implantation of a collagen sponge containing 12 mg of Recombinant human bone morphogenetic protein-2 (rhBMP-2). This study failed to detect any substantial benefit of the BMP treatment in accelerating fracture union in open tibial fractures treated with reamed intramedullary nail fixation.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
